title: [Current and future prospects of endovascular treatment for acute ischemic stroke].
abstract: Recently, remarkable progress has been made in the field of endovascular treatment, and endovascular treatment for acute ischemic stroke due to large vessel occlusion has been an effective and therapeutic option. However, there is no randomized control trial as to superiority of endovascular treatment for acute ischemic stroke compared to the standard treatment including intravenous rt-PA. Inclusion criteria for the performance of endovascular treatment for acute ischemic stroke will need to be defined more precisely, and high rates of fast recanalization will be needed in future. We expect the evidence that endovascular treatment for acute ischemic stroke due to large vessel occlusion is superior to standard treatment by the detailed images of the brain, more strict indications and novel endovascular devices such as percutaneous transluminal mechanical thrombectomy devices.
authors.affiliation: Department of Stroke Treatment, Shonan Kamakura General Hospital Stroke Center.
authors.forename: Tomonori
authors.initials: T
authors.lastname: Iwata
mesh_terms: D057510:Endovascular Procedures / Q000295:instrumentation / Q000379:methods / Q000592:standards / Q000639:trends*; D019317:Evidence-Based Medicine; D005544:Forecasting; D006801:Humans; D018579:Patient Selection; D011379:Prognosis; D011994:Recombinant Proteins / Q000008:administration & dosage; D020521:Stroke / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000295:instrumentation / Q000379:methods / Q000592:standards / Q000639:trends*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage
chemical_list: D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator